{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:08:44Z","timestamp":1789538924330,"version":"build-2803163510"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.12732","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:31:06Z","timestamp":1570620666000},"page":"e1912732","source":"Crossref","is-referenced-by-count":89,"title":["Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease"],"prefix":"10.1001","volume":"2","author":[{"given":"Romina","family":"Mariano","sequence":"first","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Messina","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurun","family":"Kumar","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Kuker","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Oxford University Hospitals National Health Service Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"issue":"7","key":"zoi190490r1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"zoi190490r2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases.","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"zoi190490r3","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"zoi190490r4","doi-asserted-by":"publisher","first-page":"1756286418762083","DOI":"10.1177\/1756286418762083","article-title":"Defining distinct features of anti-MOG antibody associated central nervous system demyelination.","volume":"11","author":"Weber","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"zoi190490r5","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"zoi190490r6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/cen3.2014.5.issue-3","article-title":"Evaluation of aquaporin-4 antibody assays.","volume":"5","author":"Waters","year":"2014","journal-title":"Clin Exp Neuroimmunol"},{"issue":"3","key":"zoi190490r7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"zoi190490r8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"zoi190490r9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","article-title":"Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.","volume":"70","author":"Kitley","year":"2013","journal-title":"JAMA Neurol"},{"issue":"5","key":"zoi190490r10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000002366","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.","volume":"86","author":"Tan","year":"2016","journal-title":"Neurology"},{"issue":"1-2","key":"zoi190490r11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2015.05.011","article-title":"Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.","volume":"355","author":"Murchison","year":"2015","journal-title":"J Neurol Sci"},{"issue":"28","key":"zoi190490r12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.msard.2018.12.011","article-title":"Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis\/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.","volume":"28","author":"Mealy","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"zoi190490r13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.msard.2016.02.014","article-title":"Neuromyelitis optica relapses: race and rate, immunosuppression and impairment.","volume":"7","author":"Tackley","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"zoi190490r14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody.","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"zoi190490r15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)30437-3","article-title":"Diagnostic algorithm for relapsing demyelinating syndromes of the CNS in children.","volume":"389","author":"Hacohen","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"zoi190490r16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2017-001845","article-title":"A practical approach to the diagnosis of spinal cord lesions.","volume":"18","author":"Mariano","year":"2018","journal-title":"Pract Neurol"},{"issue":"2","key":"zoi190490r17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol"},{"issue":"12","key":"zoi190490r18","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"zoi190490r19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients, part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"0","key":"zoi190490r20","doi-asserted-by":"publisher","first-page":"e2906","DOI":"10.1590\/1518-8345.1816.2906","article-title":"Quality of life of patients using intermittent urinary catheterization.","volume":"25","author":"Fumincelli","year":"2017","journal-title":"Rev Lat Am Enfermagem"},{"issue":"3","key":"zoi190490r21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"1","key":"zoi190490r22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/tri.12895","article-title":"Five myths about variable selection.","volume":"30","author":"Heinze","year":"2017","journal-title":"Transpl Int"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2752571\/mariano_2019_oi_190490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:31:08Z","timestamp":1570620668000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2752571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.12732","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,9]]}}}